Concentration of tunicamycin (pg/ml) Fig. 3. Effect of tunicamycin on the synthesis of peptidoglycan by etherized N. gonorrhoeae The incorporation of radioactivity from UDP-[14C]GlcNAc into hot-SDS-soluble (0) and -insoluble (0) fractions in the presence of peptidoglycan precursors was followed. tion of incorporation into the hot-SDS-insoluble fraction was 55% at 100pg of tunicamycin/ml, and higher concentrations had no greater effect. Again, the resistant 45% would appear to reflect the presence in the cells of partially synthesized teichuronic acid already inacessible to the action of tunicamycin. In the trichloroacetic acid-precipitated fraction, however, whereas the maximum inhibition was 60% at 5Opg of antibiotidml, higher drug concentrations steadily increased the observed incorporation until at 500pg/ml the residual inhibition was only 6% (Fig. 2) . Since, as in wall-plus-membrane preparations, SDSsoluble polymer was simultaneously synthesized, it seems possible that, at high tunicamycin concentrations, a greater proportion of this soluble fraction consisted of molecules sufficiently large to be co-precipitated with the cells by trichloroacetic acid. How excess tunicamycin could achieve this effect is not clear.
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The synthesis of peptidoglycan by etherized Neisseria gonorrhoeae has been described (Brown & Perkins, 1979) . In those experiments the incorporation of radioactivity from UDP-[ "CIGlcNAc into the trichloroacetic acid-precipitated fraction was inhibited by 26% by 1 pg of tunicamycin/ml. In the present work, incorporation into hot-SDS-soluble and -insoluble fractions was examined (Fig. 3) . Concentrations of tunicamycin as low as 0.005pg/ml caused a 20% fall in the synthesis of the hot-SDS-soluble fraction and an initial small rise in the synthesis of the SDS-insoluble (i.e. wall-bound) fraction. Further effects were not observed until a concentration of 10pg/ml was exceeded, when considerable inhibition of incorporation into both fractions took place. The low-concentration effect of favouring the synthesis of wall-bound material at the expense of the soluble fraction could, perhaps, represent a tendency for existing partially cross-linked chains to be extended, rather than new chains to be initiated, in the presence of the drug. Alternatively, the limited effect may imply a separate population of polymer made at highly tunicamycin-sensitive synthetic centres. In Bacillus licheniformis preparations, Ward (1 977) also observed an increase in synthesis of wall-bound peptidoglycan at low concentrations of tunicamycin.
Tunicamycin was originally isolated from cultures of Streptomyces lysosuperificus as an anti-viral agent, although subsequent work showed that it was also active against yeasts, fungi and Gram-positive bacteria, whereas Gram-negative organisms appeared to be resistant (Takatsuki et al., 1971) . Chemical analysis of tunicamycin showed it to be a family of nucleoside antibiotics containing uracil, N-acetylglucosamine, a novel amino sugar tunicamine (a C,, aminodeoxydialdose) and unsaturated fatty acids. The various members of the tunicamycin group, all of which appear to have antimicrobial activity, differ only in the chain length of the fatty acid that is esterified to the amino group of the tunicamine moiety (Takatsuki et al., 1977) . 586th MEETING, BRISTOL Tkacz & Wong (1978) have established that tunicamycin and mycospocidin, an anti-viral agent first described in 1957 (Nakamura et al., 1957), are in fact identical, and it appears likely that antibiotics of this group are produced by many Streptomyces (Mizuno et al., 1971; Eckardt et al., 1975; Kenig & Reading, 1979) .
The walls of Bacilli contain approximately 50% peptidoglycan as their main structural component. Attached to this in covalent linkage are a variety of teichoic acids and in the case of Bacillus lichenformis both teichoic and teichuronic acids. In cultures of Bacillus subtilis, treatment with tunicamycin induced cell lysis and inhibited the incorporation of glucosamine into macromolecular material (Takatsuki et al., 1972) . The effect of tunicamycin on the synthesis in uitro of both peptidoglycan and 1,3-poly(glycerol phosphate) teichoic acid has been investigated in wall-membrane preparations from an autolysin-deficient mutant of B. lichenformis (Ward, 1977) . Peptidoglycan synthesis was found to be inhibited by approximately 50% at an antibiotic concentration (IOpg. ml-l) that also inhibited growth of the organism, whereas at lower concentrations (0.5-2pg. m1-I) a stimulation of synthesis was observed. Subsequently it was found that the site of inhibition was the formation of undecaprenyl-P-P-N-acetylmuramoyl-pentapeptide, the first lipid intermediate involved in peptidoglycan synthesis. This reaction is catalysed by phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13) according to the following equation:
UDP-MurAc*-pentapeptide + C,,-P e C,,-P-P-MurAc-pentapeptide + UMP
The reaction can be assayed in both directions, either as the transfer of P-Mur Ac-pentapeptide from the nucleotide precursor to the lipid carrier or alternatively by an exchange reaction in which radioactive UMP becomes incorporated into the nucleotide precursor (Hammes & Neuhaus, 1974) . By either method, tunicamycin was found to be an effective inhibitor of the transferases from B. subtilis, B. licheniformis, Staphylococcus aureus and Micrococcus luteus, with concentrations of 1.2-5.2pg. ml-' giving 50% inhibition of exchange activity (Ward, 1977) . In B. subtilis 168 and W23 this concentration was some 3-7-fold higher than the growth-inhibitory concentration (0.2-0.5pg 9 ml-l), whereas the reverse situation existed in the other organisms examined. Penetration of antibiotics through the wall of Gram-positive bacteria is not normally considered to be a problem, suggesting that S. aureus and M. luteus may possess some mechanism of inactivating tunicamycin. Alternatively the relative resistance to autolysis of these organisms and the strain of B. lichenformis used may allow them to survive the inhibitory effect of tunicamycin. The role of autolysins in the bactericidal effects of other antibiotics known to inhibit peptidoglycan synthesis has already been described (Rogers & Forsberg, 197 I) . In contrast, antibiotic-resistance in Gram-negative bacteria has frequently been associated with the inability of these antibiotics to penetrate the outer membrane either because of their size or their hydrophobicity (Nikaido, 1979) . The outer membrane presents a barrier particularly to substances having a molecular weight greater than 600-700 [the molecular weight of tunicamycin is approx. 830 (Takatsuki et al., 1977) l. Formation of the second lipid intermediate in peptidoglycan requires the transfer of N-acetylglucosamine from UDP-Nacetylglucosamine to undecaprenyl-P-P-MurAc-pentapeptide. This reaction is not inhibited by tunicamycin (Ward, 1977) . A similar situation exists in the formation of dolichol-P-P-di-Nacetylchitobiose by membrane preparations of Saccharomyces cerevisiae; tunicamycin inhibits the synthesis of dolichol-P-P-Nacetylglucosamine but not the subsequent transfer of a second N-acetylglucosamine residue (Lehle & Tanner, 1976) .
Abbreviations; MurAc, acetylmuramoyl; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine.
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Lipid intermediates have also been shown to participate in the biosynthesis of linkage units interposed between peptidoglycan and the teichoic acids of Bacilli, S. aureus and Micrococcus sp. 2102 (Bracha & Glaser, 1976; Wyke & Ward, 1977; McArthur et al., 1978; Coley et al., 1978) and the teichuronic acid of M. luteus (Rohr et al., 1977; Weston & Perkins, 1977) . In each of the teichoic acids the linkage unit appears to be synthesized by the translocation of phospho-N-acetylglucosamine from the nucleotide precursor to a polyprenyl phosphate followed by the addition of one to three glycerol phosphate residues from CDPglycerol. The resulting polyprenyl-P-P-linkage unit then accepts the main teichoic acid chain before the complete polymer becomes covalently linked to the peptidoglycan. Thus the first enzyme involved in the biosynthesis of wall teichoic acids is a phospho-N-acetylglucosamine translocase catalysing the following reaction:
This reaction, which is analogous to the one involved in yeast glycoprotein biosynthesis, can also be assayed in both directions. It is extremely sensitive to tunicamycin: a concentration of 0.2pg. ml-' results in approximately 60% inhibition of the exchange activity assayed in membrane preparations from B. lichenformis. However, much higher concentrations (5pg.ml-I) were required to inhibit by 50% the linkage of teichoic acid to peptidoglycan in wall-membrane preparations from this organism. Possibly the enzyme preparation contained preformed polyprenyl-P-P-GlcNAc to which some of the newly synthesized teichoic acid could be linked. In B. subtilis W23 linkage of the poly(ribito1 phosphate) teichoic acid to the wall was extremely sensitive to tunicamycin, more than 90% inhibition occurring at an antibiotic concentration of 1 pg . m1-I. The linkage of the teichoic acid was not inhibited if the wall-membrane preparation was preincubated with UDP-GlcNAc before the addition of the antibiotic (Wyke & Ward, 1977) .
Although not yet established, it seems probable that the lipid carriers participating in biosynthesis of teichoic acid and peptidoglycan is undecaprenyl phosphate for both. The use of a common carrier could be an important point in the regulation and co-ordination of wall-polymer assembly. It is in this context that an explanation might be found for the observation described above that low concentrations of tunicamycin appear to stimulate rather than inhibit peptidoglycan synthesis. The greater sensitivity of phospho-N-acetylglucosamine translocase could prevent utilization of undecaprenyl phosphate for the synthesis of teichoic acid linkage units and thus make more of the lipid carrier available for use in peptidoglycan synthesis.
Recently we have found that lipid intermediates also participate in the biosynthesis of teichuronic acid in B. lichenformis. Synthesis of this polymer was found to be sensitive to bacitracin but not to tunicamycin, suggesting the involvement of a lipid intermediate but not one that contains a linkage unit of the teichoic acid type. Bacitracin speciflcally inhibits the dephosphorylation of undecaprenyl pyrophosphate (Siewert & Strominger, 1967) and establishes this to be one of the products of biosynthesis. Other experiments have shown that teichuronic acid is synthesized by the alternate transfer of phospho-Nacetylgalactosamine and glucuronic acid residues to a prenyl phosphate carrier, once again presumed to be undecaprenyl phosphate. The disaccharides are then polymerized, the polymer being extended by addition of the newly synthesized units at the reducing terminal with the concomitant release of undecaprenyl pyrophosphate. Finally, the completed polymer is covalently linked to peptidoglycan by the formation of a phosphodiester bond between the reducing N-acetylgalactosamine residue of the teichuronic acid and the 6-position of an N-acetylmuramic acid residue in the glycan. Thus the first reaction involved in the biosynthesis of teichuronic acid is catalysed by a phospho-N-acetylgalactosamine translocase as follows:
UDPGalNAc + C,,-P* C,,-P-P-GalNAc + UMP UDP-GIcNAc + CSgP* C,,-P-P-GlcNAc + UMP By using membrane preparations from B. licheniformis, this enzyme has been assayed in both directions and found to be resistant to tunicamycin (1OOpg. ml-').
Therefore in wall-polymer assembly in B. licheniformis, B. subtilis and S . aureus tunicamycin has been shown to inhibit the biosynthesis of both peptidoglycan and the linkage units involved in the attachment of teichoic acids to peptidoglycan. Although in B. licheniformis a 5-fold difference was observed in the concentration of tunicamycin required to inhibit the two translocases, the known structural role of peptidoglycan points to inhibition of the synthesis of this polymer being responsible for the observed antibacterial activity. If, as suggested (Heifetz  et al., 1979) , tunicamycin acts as a substrate-product transition-state analogue binding irreversibly to sensitive enzymes, then the differences observed in the concentration of antibiotic required to inhibit the sensitive translocases in B. licheniformis may be a reflection of the affinity of tunicamycin for the two active sites.
Finally, when considering the action of tunicamycin in terms of the experimental results obtained in bacteria, yeast and mammalian systems, the following common features become apparent. All the sensitive enzymes, with the possible exception of the one involved in the incorporation of N-acetylglucosamine into the linkage unit of M . luteus teichuronic acid (Rohr et al., 1977 ; Weston & Perkins, 1977) , appear to involve the translocation of phospho-N-acetylglucosamine or its derivatives to a lipid acceptor. In this context phospho-N-acetylmuramoyl-pentapeptide can be regarded as a peptide-substituted 3-0-lactyl ether of Nacetylglucosamine. The amphipathic character of tunicamycin may be of major importance in the recognition of the polyprenyl phosphate acceptor in its membrane environment. Perhaps more surprising is the finding that, although the majority if not all of the sensitive enzymes catalyse the transfer of phosphorylated residues, tunicamycin itself does not contain phosphorus.
